CA Patent

CA2066898A1 — Pharmaceutical compounds

Assigned to Eli Lilly and Co · Expires 1992-10-30 · 34y expired

What this patent protects

ABSTRACT 2-amino-4-hydroxypyrido[2,3-d]pyrimidines, having a 6-substituted ethyl or ethenyl group, are useful antineoplastic agents.

USPTO Abstract

ABSTRACT 2-amino-4-hydroxypyrido[2,3-d]pyrimidines, having a 6-substituted ethyl or ethenyl group, are useful antineoplastic agents.

Drugs covered by this patent

Patent Metadata

Patent number
CA2066898A1
Jurisdiction
CA
Classification
—
Expires
1992-10-30
Drug substance claim
No
Drug product claim
No
Assignee
Eli Lilly and Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.